Editorial comment.
Kassouf
Wassim
W
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D002278:Carcinoma in Situ / Q000473:pathology* / Q000628:therapy*; D015653:Cystectomy; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000556:secondary* / Q000628:therapy*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine